Financhill
Back

Salesforce Vs. Lyra Therapeutics Industry Stock Comparison

Buy
59

CRM
Salesforce

Last Price:
$269.74
Seasonality Move:
8.88%
Sell
32

LYRA
Lyra Therapeutics

Last Price:
$9.10
Seasonality Move:
-2.29%
Buy
59
Salesforce (CRM) is a Buy

Is Salesforce a Buy, Sell or Hold?

  • The current Salesforce [CRM] share price is $272.15. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics a Buy, Sell or Hold?

  • The current Lyra Therapeutics [LYRA] share price is $9.00. The Score for LYRA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • LYRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRM Stock Price Chart

What is Salesforce's stock price today?

  • The Salesforce share price today is $272.15
    The current trend is moderately bullish and CRM is experiencing slight buying pressure.

LYRA Stock Price Chart

What is Lyra Therapeutics's stock price today?

  • The Lyra Therapeutics share price today is $9.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing slight selling pressure.

CRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.17 Buy
Relative Strength Index (14 RSI): 53.23 Buy
Chaikin Money Flow: 236955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (262.44 - 271.48) Buy
Bollinger Bands (100): (256.67 - 299.17) Sell

LYRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 44.26 Sell
Chaikin Money Flow: -16263 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.53 - 19.57) Sell
Bollinger Bands (100): (4.06 - 13.18) Buy

CRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 271.13 Buy
20-day SMA: 267.63 Buy
50-day SMA: 272.03 Buy
200-day SMA: 296.46 Sell
8-day EMA: 270.22 Buy
20-day EMA: 269.03 Buy
50-day EMA: 254.96 Buy
200-day EMA: 139.4 Buy

LYRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.48 Sell
20-day SMA: 12.91 Sell
50-day SMA: 9.32 Sell
200-day SMA: 9.78 Sell
8-day EMA: 10.03 Sell
20-day EMA: 11.05 Sell
50-day EMA: 10.19 Sell
200-day EMA: 21.81 Sell

Salesforce Earnings Growth & CRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.

Lyra Therapeutics Earnings Growth & LYRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

Salesforce Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):